Blachem (BCPC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

This growth model looks for low book-to-market stocks that exhibit characteristics associated with sustained future growth. BALCHEM CORP ( BCPC ) is a mid-cap growth stock in the Biotechnology ...

Investors interested in Chemical - Specialty stocks are likely familiar with Celanese (CE) and Blachem (BCPC). But which of these two stocks is more attractive to value investors? We'll need to ...

Looking at the chart above, BCPC's low point in its 52 week range is $48.89 per share, with $69.92 as the 52 week high point — that compares with a last trade of $55.61. Find out what 9 other ...

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.

The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, BCPC has a P/B of 3.97.

See why Balchem Corporation's valuation and macroeconomic pressures suggest a 'Hold' rating despite strong Q4 2024 growth in key segments. Click for my BCPC update.

Looking at the chart above, BCPC's low point in its 52 week range is $48.89 per share, with $69.92 as the 52 week high point — that compares with a last trade of $52.45.